-
Je něco špatně v tomto záznamu ?
Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression
M. Zeman, M. Vecka, M. Jáchymová, R. Jirák, E. Tvrzická, B. Staňková, A. Žák
Jazyk angličtina Země Japonsko
Grantová podpora
NR8806
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 1920
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
od 1920
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
od 1920
Open Access Digital Library
od 1920-01-01
Medline Complete (EBSCOhost)
od 2006-11-01
- MeSH
- chromatografie plynová MeSH
- deprese metabolismus MeSH
- financování organizované MeSH
- fosfatidylcholiny krev MeSH
- inzulin krev MeSH
- jednonukleotidový polymorfismus genetika MeSH
- koenzym A-ligasy genetika MeSH
- krevní glukóza MeSH
- kyselina 8,11,14-eikosatrienová krev MeSH
- kyselina arachidonová krev MeSH
- lidé MeSH
- mastné kyseliny metabolismus MeSH
- metabolický syndrom metabolismus MeSH
- polymerázová řetězová reakce MeSH
- polymorfismus délky restrikčních fragmentů MeSH
- radioimunoanalýza MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
The composition of polyunsaturated fatty acids (PUFAs) in cell membranes and body tissues is altered in metabolic syndrome (MetS) and depressive disorder (DD). Within the cell, fatty acid coenzyme A (CoA) ligases (FACLs) activate PUFAs by esterifying with CoA. The FACL4 isoform prefers PUFAs (arachidonic and eicosapentaenoic acid) as substrates, and the FACL4 gene is mapped to Xq23. We have analyzed the association between the common single nucleotide polymorphism (SNP) (rs1324805, C to T substitution) in the first intron of the FACL4 gene and MetS or DD. The study included 113 healthy subjects (54 Males/59 Females), 56 MetS patients (34M/22F) and 41 DD patients (7M/34F). In MetS group, T-carriers and patients with CC or C0 (CC/C0) genotype did not differ in the values of metabolic indices of MetS and M/F ratio. Nevertheless, in comparison with CC/C0, the T-allele carriers were characterized by enhanced unfavorable changes in fatty acid metabolism typical for MetS: higher content of dihomogammalinolenic acid (P < 0.05) and lower content of arachidonic acid in plasma phosphatidylcholine (PC) (P = 0.052), lower index of Delta5 desaturation (P < 0.01) and unsaturation index (UI) (P < 0.001). In contrast, DD patients had higher concentrations of plasma glucose, insulin, conjugated dienes and index of insulin resistance, but showed no significant association with the studied SNP. The present study shows that the common SNP (C to T substitution) in the first intron of the FACL4 gene is associated with altered FA composition of plasma phosphatidylcholines in patients with MetS.
- 000
- 03488naa 2200481 a 4500
- 001
- bmc11009454
- 003
- CZ-PrNML
- 005
- 20150818111803.0
- 008
- 110510s2009 ja e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Zeman, Miroslav, $d 1950- $7 skuk0006053
- 245 10
- $a Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression / $c M. Zeman, M. Vecka, M. Jáchymová, R. Jirák, E. Tvrzická, B. Staňková, A. Žák
- 314 __
- $a Charles University in Prague, First Faculty of Medicine, 4th Department of Internal Medicine, General Teaching Hospital in Prague, Prague, Czech Republic. mirozem@centrum.cz
- 520 9_
- $a The composition of polyunsaturated fatty acids (PUFAs) in cell membranes and body tissues is altered in metabolic syndrome (MetS) and depressive disorder (DD). Within the cell, fatty acid coenzyme A (CoA) ligases (FACLs) activate PUFAs by esterifying with CoA. The FACL4 isoform prefers PUFAs (arachidonic and eicosapentaenoic acid) as substrates, and the FACL4 gene is mapped to Xq23. We have analyzed the association between the common single nucleotide polymorphism (SNP) (rs1324805, C to T substitution) in the first intron of the FACL4 gene and MetS or DD. The study included 113 healthy subjects (54 Males/59 Females), 56 MetS patients (34M/22F) and 41 DD patients (7M/34F). In MetS group, T-carriers and patients with CC or C0 (CC/C0) genotype did not differ in the values of metabolic indices of MetS and M/F ratio. Nevertheless, in comparison with CC/C0, the T-allele carriers were characterized by enhanced unfavorable changes in fatty acid metabolism typical for MetS: higher content of dihomogammalinolenic acid (P < 0.05) and lower content of arachidonic acid in plasma phosphatidylcholine (PC) (P = 0.052), lower index of Delta5 desaturation (P < 0.01) and unsaturation index (UI) (P < 0.001). In contrast, DD patients had higher concentrations of plasma glucose, insulin, conjugated dienes and index of insulin resistance, but showed no significant association with the studied SNP. The present study shows that the common SNP (C to T substitution) in the first intron of the FACL4 gene is associated with altered FA composition of plasma phosphatidylcholines in patients with MetS.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a kyselina 8,11,14-eikosatrienová $x krev $7 D015126
- 650 _2
- $a kyselina arachidonová $x krev $7 D016718
- 650 _2
- $a krevní glukóza $7 D001786
- 650 _2
- $a chromatografie plynová $7 D002849
- 650 _2
- $a koenzym A-ligasy $x genetika $7 D003066
- 650 _2
- $a deprese $x metabolismus $7 D003863
- 650 _2
- $a mastné kyseliny $x metabolismus $7 D005227
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x krev $7 D007328
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolický syndrom $x metabolismus $7 D024821
- 650 _2
- $a fosfatidylcholiny $x krev $7 D010713
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a polymorfismus délky restrikčních fragmentů $7 D012150
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 650 _2
- $a radioimunoanalýza $7 D011863
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Vecka, Marek, $d 1976- $7 xx0076497
- 700 1_
- $a Jáchymová, Marie $7 xx0072686
- 700 1_
- $a Jirák, Roman, $d 1943- $7 jn19990209313
- 700 1_
- $a Tvrzická, Eva $7 xx0076496
- 700 1_
- $a Staňková, Barbora $7 xx0133413
- 700 1_
- $a Žák, Aleš, $d 1951- $7 mzk2007382175
- 773 0_
- $t Tohoku Journal of Experimental Medicine $w MED00010689 $g Roč. 217, č. 4 (2009), s. 287-293 $x 0040-8727
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110513105350 $b ABA008
- 991 __
- $a 20150818111910 $b ABA008
- 999 __
- $a ok $b bmc $g 839017 $s 702839
- BAS __
- $a 3
- BMC __
- $a 2009 $b 217 $c 4 $d 287-293 $m Tohoku journal of experimental medicine $n Tohoku J Exp Med $x MED00010689 $i 0040-8727
- GRA __
- $a NR8806 $p MZ0
- LZP __
- $a 2011-2B09/jvme